Cargando…

Coupling relationship between glucose and oxygen metabolisms to differentiate preclinical Alzheimer's disease and normal individuals

The discovery of preclinical Alzheimer's disease (preAD) provides a wide time window for the early intervention of AD. The coupling relationships between glucose and oxygen metabolisms from hybrid PET/MRI can provide complementary information on the brain's physiological state for preAD. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Changchang, Du, Wenying, Zhang, Qi, Wang, Luyao, Han, Ying, Jiang, Jiehui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449101/ https://www.ncbi.nlm.nih.gov/pubmed/34291850 http://dx.doi.org/10.1002/hbm.25599

Ejemplares similares

Generative adversarial network constrained multiple loss autoencoder: A deep learning‐based individual atrophy detection for Alzheimer's disease and mild cognitive impairment
por: Shi, Rong, et al.
Publicado: (2022)

Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease()
por: Chételat, Gaël, et al.
Publicado: (2013)

A metabolism‐functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans
por: Wang, Luyao, et al.
Publicado: (2023)

Alanine Aminotransferase Is Associated with an Adverse Nocturnal Blood Glucose Profile in Individuals with Normal Glucose Regulation
por: Zhou, Jian, et al.
Publicado: (2013)

Mapping the Relationship of Contributing Factors for Preclinical Alzheimer’s Disease
por: Shi, Lin, et al.
Publicado: (2015)

MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
por: Wang, Ting, et al.
Publicado: (2023)

Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance
por: Castaldo, Ersilia, et al.
Publicado: (2011)

Differential Abnormality in Functional Connectivity Density in Preclinical and Early-Stage Alzheimer's Disease
por: Song, Yu, et al.
Publicado: (2022)

Using Deep Learning Radiomics to Distinguish Cognitively Normal Adults at Risk of Alzheimer’s Disease From Normal Control: An Exploratory Study Based on Structural MRI
por: Jiang, Jiehui, et al.
Publicado: (2022)

Amyloid β deposition and glucose metabolism on the long-term progression of preclinical Alzheimer's disease
por: Hatashita, Shizuo, et al.
Publicado: (2019)

Individual Proportion Loss of Functional Connectivity Strength: A Novel Individual Functional Connectivity Biomarker for Subjective Cognitive Decline Populations
por: Li, Zhuoyuan, et al.
Publicado: (2023)

Topological properties of individual gray matter morphological networks in identifying the preclinical stages of Alzheimer’s disease: a preliminary study
por: Ding, Hongyuan, et al.
Publicado: (2023)

Unlocking the enigma: unraveling multiple cognitive dysfunction linked to glymphatic impairment in early Alzheimer’s disease
por: Zhong, Jiayi, et al.
Publicado: (2023)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment
por: Li, Lanlan, et al.
Publicado: (2021)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: a cross-sectional analysis from the SILCODE study
por: Sheng, Can, et al.
Publicado: (2022)

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
por: Lazarczyk, Maciej J, et al.
Publicado: (2012)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Altered Frequency-Dependent Brain Activation and White Matter Integrity Associated With Cognition in Characterizing Preclinical Alzheimer’s Disease Stages
por: Wang, Siyu, et al.
Publicado: (2021)

Morning cortisol is lower in obese individuals with normal glucose tolerance
por: Praveen, Edavan P, et al.
Publicado: (2011)

Pre‐amyloid stage of Alzheimer's disease in cognitively normal individuals
por: Tijms, Betty M., et al.
Publicado: (2018)

Alzheimer’s disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals
por: Pettigrew, Corinne, et al.
Publicado: (2023)

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
por: Khan, Tapan K.
Publicado: (2018)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

Relationship of fasting glucose and longitudinal Alzheimer's disease imaging markers
por: Honea, Robyn A., et al.
Publicado: (2022)

Individual and Combined Impact of Oxygen and Oxygen Transporter Supplementation during Kidney Machine Preservation in a Porcine Preclinical Kidney Transplantation Model
por: Kasil, Abdelsalam, et al.
Publicado: (2019)

The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
por: de Leon, Mony J., et al.
Publicado: (2018)

Physiological Oxygen Levels Differentially Regulate Adipokine Production in Abdominal and Femoral Adipocytes from Individuals with Obesity Versus Normal Weight
por: Lempesis, Ioannis G., et al.
Publicado: (2022)

Relationship between serum adipsin and the first phase of glucose‐stimulated insulin secretion in individuals with different glucose tolerance
por: Zhou, Qing, et al.
Publicado: (2018)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging
por: Podtelezhnikov, Alexei A., et al.
Publicado: (2011)

Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer’s Disease
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2023)

Preclinical diagnosis of Alzheimer’s disease: Prevention or prediction?
por: Nitrini, Ricardo
Publicado: (2010)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease
por: Kulason, Sue, et al.
Publicado: (2020)

Retinal layer thickness in preclinical Alzheimer's disease
por: van de Kreeke, Jacoba A., et al.
Publicado: (2019)

Onset of Preclinical Alzheimer Disease in Monozygotic Twins
por: Konijnenberg, Elles, et al.
Publicado: (2021)

Gut microbiome alterations in preclinical Alzheimer’s disease
por: Jung, Joon Hyung, et al.
Publicado: (2022)

Precipitating Mechanisms of Falls in Preclinical Alzheimer’s Disease
por: Keleman, Audrey A., et al.
Publicado: (2023)

Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer’s disease
por: Parasoglou, Prodromos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t3o52t7pba8lb97mm69sgs7s9o